Cari Tuna and Dustin Moskovitz
Former Wall Street Journal reporter Cari Tuna and husband Dustin Moskovitz, co-founder of Facebook and the productivity platform Asana, launched their foundation Good Ventures in 2011 with an ambitious mission to 'improve as many lives as possible, as much as possible' in an effort to help humanity 'thrive.' The couple, both Giving Pledge signatories, are also among the founders of Open Philanthropy, a grantmaker that advises major donors, including Tuna and Moskovitz, on how to maximize the impact of their giving.
Good Ventures and Open Philanthropy favor a data-centric approach, intended to direct dollars to causes where they can do the most good. Tuna, who is co-founder and chair of Good Ventures and chair of Open Philanthropy, says that approach involves considering three key criteria in deciding which causes to focus on: neglectedness, importance, and tractability (how hard it might be to solve). She says, "If we are only giving to the things that are important to us as donors then we are missing a whole swath of other opportunities to improve people's lives, especially the causes that are affecting the most disadvantaged people in the world."
That strategy has led Tuna and Moskovitz to direct their money to a wide range of causes they consider underfunded, including the prevention of lead poisoning and illness due to poor air quality. Open Philanthropy is also one of the biggest philanthropic funders of research on AI safety. In March, Open Philanthropy also launched a $120 million fund, with half of the money coming from Good Ventures, to fund research and advocacy to reduce regulatory and other barriers to housing and green energy infrastructure development.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
IVF parents are spending thousands to predict their babies' chances of having Alzheimer's, cancer and heart disease
Maybe she's born with it, maybe it's … genetic optimization? Prospective parents using in vitro fertilization (IVF) will soon be able to select embryos based on their potential risk for diseases — including illnesses that develop later in life — thanks to a groundbreaking $5,999 service announced this week by a US biotech company. 'Before there's a heartbeat, there's DNA,' Kian Sadeghi, founder and chief executive of Nucleus Genomics, said in a statement. 'One file containing DNA and genetic markers can tell you more about your baby's future than any other test a doctor could possibly run at this stage.' The popular fertility treatment involves removing eggs from a woman's ovaries and fertilizing them with sperm in a lab. The resulting embryo — which could be frozen or fresh — is placed into the uterus, where it hopefully implants in the uterine wall and sparks a pregnancy. Before implantation, many IVF clinics already screen embryos for genetic abnormalities — such as extra chromosomes or gene mutations — that can lead to failed implantations, miscarriages, birth defects or inherited disorders. But the first-of-its-kind service from Nucleus Genomics takes things a step further. The company just launched Nucleus Embryo, a new software platform that lets potential parents dig deep into the full genetic blueprint of their embryos before choosing which one to implant. The tool lets IVF patients compare the DNA of up to 20 embryos, screening them for more than 900 conditions — including Alzheimer's, Type 2 diabetes, heart disease and several forms of cancer. It doesn't stop there. The program also flags potential mental health conditions like depression and schizophrenia and even ranks cognitive traits like IQ. Parents can also get a look at cosmetic and physical features, from height, baldness and BMI to eye and hair color. The company isn't promising perfection. Instead, the software generates a so-called polygenic risk score that will give parents the probability of how likely it is an embryo might develop certain traits or diseases. Ultimately, it's up to the parents to decide which qualities matter most to them. For those looking to decode the results, genetic counseling sessions are available. 'Lifespan has dramatically increased in the last 150 years,' Sadeghi told the Wall Street Journal. 'DNA testing to predict and reduce chronic disease can make it happen again.' The practice, known as polygenic embryo screening, is already highly controversial in the medical world, according to a report published by Harvard Law School's Petrie-Flom Center. Critics warn that allowing parents to screen embryos for risks like depression or diabetes could deepen stigma and discrimination against people living with those conditions. Meanwhile, disability advocates argue it promotes the harmful idea that disability is something to be fixed, not a natural part of human diversity. And when it comes to choosing embryos for traits like intelligence or athleticism, critics say we're sliding into designer baby territory — a modern form of eugenics that favors the rich, reinforcing social and healthcare inequalities. Still, the public appears open to some aspects of the tech. A 2023 survey found that 77% of Americans support using it to screen embryos for the likelihood of developing certain physical conditions, while 72% back screening for mental health risks. Proponents argue it's no different from vaccination — a preventive tool, not a judgment on those with the condition. But when it comes to non-medical traits, support drops fast: only 36% back screening embryos for behavioral traits and just 30% for physical features like height or eye color.
Yahoo
8 hours ago
- Yahoo
White House tries to water down Russia sanctions
Donald Trump is pressuring a US senator to weaken a Bill that would impose sweeping sanctions on Russia. White House officials hoping to mend relations with Moscow have been quietly contacting senator Lindsey Graham's office urging him to water down his Bill, which aims to cripple Vladimir Putin with huge sanctions. The Bill, backed by nearly the entire Senate, would impose 500 per cent tariffs on countries that continue to buy Russian oil and gas, which bankrolls Putin's war effort. Officials have been demanding the Bill include waivers that would allow Mr Trump to choose who or what was sanctioned, congressional aides told the Wall Street Journal. Other attempts to weaken the legislation include softening the language, replacing 'shall' with 'may' to avoid making the reprimands mandatory. Removing the mandatory nature of the sanctions would render the Bill effectively toothless and do little to hamper Putin's war machine, aides fear. 'We're moving ahead and the White House is included in our conversations,' Richard Blumenthal, senator and lead Democratic co-sponsor of the Bill, told the paper. Russia's war effort is funded by fossil-fuel exports. Moscow has adapted to existing sanctions with relative ease, turning to North Korea and China for support. Fearing the impact on pump prices, Joe Biden, former president, was unwilling to crack down on Russian energy exports. Mr Trump, has threatened to impose sanctions on Ukraine, as well as Russia, if the two sides fail to reach a peace agreement. 'Any sanction package must provide complete flexibility for the president to continue to pursue his desired foreign policy,' a White House official said. They added that the constitution 'vests the president with the authority to conduct diplomacy with foreign nations'. Speaking in the Oval Office alongside Friedrich Merz, German chancellor, on Thursday, the US president said that the Bill should not move forward without his express approval. 'They'll be guided by me. That's how it's supposed to be,' he told reporters. 'They're waiting for me to decide on what to do.' Last week, Mr Graham and Mr Blumenthal visited Ukraine where they applauded the country's drone attack that destroyed 40 aircraft deep inside Russian territory. However, they were ridiculed and accused of 'stirring up' the conflict by key allies of Mr Trump, including Steve Bannon. 'By trying to engage Putin – by being friendly and enticing – it's become painfully clear [Putin's] not interested in ending this war,' Mr Graham said earlier this week. '[Putin] needs to see and hear that message as well from us, from the American people,' said Mr Blumenthal. Both said that failing to act now could pull the US deeper into the conflict later. If Putin isn't stopped in Ukraine, Mr Blumenthal said, Nato treaty obligations could compel US troops into battle. Earlier this week, Russian negotiators tabled a long memorandum, resembling a complete capitulation for Ukraine, in a second round of direct talks with Kyiv in Istanbul. They demanded Ukraine must withdraw its troops from four eastern regions that Russia only partially occupies and that international recognition of Russian sovereignty over them and Crimea must be granted. Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
American Military News
9 hours ago
- American Military News
Iran orders ballistic missile materials from China for hundreds of missiles: Report
A new report claims that Iran has ordered thousands of tons of ballistic missile materials from China that could be used for hundreds of ballistic missiles. The report comes as Iran continues to negotiate with the United States regarding a nuclear program deal. The Wall Street Journal reported that Iran has ordered thousands of tons of ammonium perchlorate from China. The outlet noted that ammonium perchlorate is a chemical compound that is used in ballistic missiles. According to the Wall Street Journal, sources claimed that Iran is expected to receive China's shipments of ammonium perchlorate in the coming months and that the chemical compound could potentially be used in hundreds of ballistic missiles. The sources said Pishgaman Tejarat Rafi Novin Co., an Iranian company, purchased the ammonium perchlorate from Lion Commodities Holdings Ltd., a company based in Hong Kong. The New York Post reported that a portion of the ammonium perchlorate reportedly purchased from China will likely be used in ballistic missiles supplied to Iran-backed terrorist organizations in the Middle East, including the Houthis terrorist organization, which has repeatedly attacked military and commercial ships in the Red Sea and has carried out attacks against Israel. READ MORE: Russia funding new Iranian nuclear plants, Iranian official says In April, the Treasury Department announced that it was designating 'six entities and six individuals based in Iran and the People's Republic of China (PRC) for their role in a network procuring ballistic missile propellant ingredients on behalf of Iran's Islamic Revolutionary Guard Corps (IRGC).' The Treasury Department warned that the network of individuals and entities had helped Iran obtain materials used in ballistic missiles from China. 'Iran's aggressive development of missiles and other weapons capabilities imperils the safety of the United States and our partners, Treasury Secretary Scott Bessent said at the time. 'It also destabilizes the Middle East, and violates the global agreements intended to prevent the proliferation of these technologies. To achieve peace through strength, Treasury will continue to take all available measures to deprive Iran's access to resources necessary to advance its missile program.' In a public speech on Tuesday, Iranian Supreme Leader Supreme Leader Ayatollah Ali Khamenei rejected a nuclear deal with the United States, saying, 'The rude and arrogant leaders of America repeatedly demand that we should not have a nuclear program. Who are you to decide whether Iran should have enrichment?' Following Iran's rejection of a nuclear deal with the United States, Trump issued a statement on Truth Social, warning that 'time is running out on Iran's decision pertaining to nuclear weapons.' Trump added, 'It is my opinion that Iran has been slowwalking their decision on this very important matter, and we will need a definitive answer in a very short period of time!'
